The text discusses the treatment of stage II colon cancer, which has a heterogeneous pathology and prognosis. The effectiveness of adjuvant chemotherapy for stage II colon cancer is unclear, with conflicting results from various studies and meta-analyses. Some studies suggest a benefit, while others do not show any advantage.